Weir JP - Search Results

1

Changes of the receptor-binding properties of influenza B virus B/Victoria/504/2000 during adaptation in chicken eggs.

Lugovtsev VY, Smith DF, Weir JP. Lugovtsev VY, et al. Among authors: weir jp. Virology. 2009 Nov 25;394(2):218-26. doi: 10.1016/j.virol.2009.08.014. Epub 2009 Sep 19. Virology. 2009. PMID: 19766280 Free article.

2

Inducible gene expression of the human immunodeficiency virus LTR in a replication-incompetent herpes simplex virus vector.

Warden MP, Weir JP. Warden MP, et al. Among authors: weir jp. Virology. 1996 Dec 1;226(1):127-31. doi: 10.1006/viro.1996.0635. Virology. 1996. PMID: 8941330 Free article.

3

Characterization of the initiator and downstream promoter elements of herpes simplex virus 1 late genes.

Woerner AM, Weir JP. Woerner AM, et al. Among authors: weir jp. Virology. 1998 Sep 30;249(2):219-30. doi: 10.1006/viro.1998.9339. Virology. 1998. PMID: 9791014 Free article.

4

Herpes simplex virus 1 late gene expression is preferentially inhibited during infection of the TAF250 mutant ts13 cell line.

Dhar S, Weir JP. Dhar S, et al. Among authors: weir jp. Virology. 2000 Apr 25;270(1):190-200. doi: 10.1006/viro.2000.0259. Virology. 2000. PMID: 10772991 Free article.

5

Tetracycline-regulated gene expression in replication-incompetent herpes simplex virus vectors.

Schmeisser F, Donohue M, Weir JP. Schmeisser F, et al. Among authors: weir jp. Hum Gene Ther. 2002 Dec 10;13(18):2113-24. doi: 10.1089/104303402320987815. Hum Gene Ther. 2002. PMID: 12542843

6

DNA immunization with a herpes simplex virus 2 bacterial artificial chromosome.

Meseda CA, Schmeisser F, Pedersen R, Woerner A, Weir JP. Meseda CA, et al. Among authors: weir jp. Virology. 2004 Jan 5;318(1):420-8. doi: 10.1016/j.virol.2003.09.033. Virology. 2004. PMID: 14972567 Free PMC article.

7

Enhanced immunogenicity and protective effect conferred by vaccination with combinations of modified vaccinia virus Ankara and licensed smallpox vaccine Dryvax in a mouse model.

Meseda CA, Garcia AD, Kumar A, Mayer AE, Manischewitz J, King LR, Golding H, Merchlinsky M, Weir JP. Meseda CA, et al. Among authors: weir jp. Virology. 2005 Sep 1;339(2):164-75. doi: 10.1016/j.virol.2005.06.002. Virology. 2005. PMID: 15993917 Free article.

8

Identification and preliminary characterization of vaccinia virus (Dryvax) antigens recognized by vaccinia immune globulin.

Jones-Trower A, Garcia A, Meseda CA, He Y, Weiss C, Kumar A, Weir JP, Merchlinsky M. Jones-Trower A, et al. Among authors: weir jp. Virology. 2005 Dec 5;343(1):128-40. doi: 10.1016/j.virol.2005.08.008. Epub 2005 Sep 13. Virology. 2005. PMID: 16165184 Free article.

9

Microarray assay for evaluation of the genetic stability of modified vaccinia virus Ankara B5R gene.

Laassri M, Meseda CA, Williams O, Merchlinsky M, Weir JP, Chumakov K. Laassri M, et al. Among authors: weir jp. J Med Virol. 2007 Jun;79(6):791-802. doi: 10.1002/jmv.20889. J Med Virol. 2007. PMID: 17457926

10

FDA/NIH/WHO public workshop on immune correlates of protection against influenza A viruses in support of pandemic vaccine development, Bethesda, Maryland, US, December 10-11, 2007.

Eichelberger M, Golding H, Hess M, Weir J, Subbarao K, Luke CJ, Friede M, Wood D. Eichelberger M, et al. Vaccine. 2008 Aug 12;26(34):4299-303. doi: 10.1016/j.vaccine.2008.06.012. Epub 2008 Jun 26. Vaccine. 2008. PMID: 18582523

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results